Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through IL-6/JAK2/STAT3 signaling axis

被引:12
|
作者
Pradhan, Rajalaxmi [1 ]
Paul, Subarno [1 ]
Acharya, Sushree Subhadra [1 ]
Sinha, Saptarshi [1 ]
Dash, Somya Ranjan [1 ]
Kundu, Chanakya Nath [1 ,2 ]
机构
[1] Kalinga Inst Ind Technol, Sch Biotechnol, Canc Biol Div, Bhubaneswar, Orissa, India
[2] Campus 11, Bhubaneswar 751024, Orissa, India
来源
关键词
Cancer associated fibroblasts (CAFs); Cancer stem cells (CSCs); Cytokines; Metastasis; Oral cancer; Resveratrol-nanoparticle; Activated macrophages-M1 (AM-M1);
D O I
10.1016/j.jnutbio.2024.109568
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor associated macrophages (TAMs) and cancer -associated fibroblasts (CAFs) in the tumor microenvironment secrete several cytokines, which involved in tumor initiation, progression, metastatic outgrowth and angiogenesis. However, the association between TAMs and CAFs in the context of tumor development remain unclear. Here, we studied the relationship between TAMs and CAFs along with the involvement of cytokines in the production of cancer -stem -like -cells (CSCs) in oral cancer cells and explored the potential anticancer effects of Nano -formulated Resveratrol (Res -NP) using an activated macrophage -M1 (AM -M1) and activated fibroblast cells as the model system. IL -6 secretion was found to be enhanced in the conditioned -medium (CM) when AM -M1 cells + CAFs-like cells were cocultured together. CSCs-enriched population was developed after addition of CM of AM -M1 + CAFs in H-357 cells and patient -derived -primary -oral -cancer cells. AM -M1 cells + CAFs-like cells secreted IL -6 enhanced CSCs growth, proliferation, metastasis, and angiogenesis. IL -6 was found to promote PD -L1 expression in CSCs-enriched cells via JAK2/STAT3 pathway, as evident from the enhanced expression of p-JAK2 and p-STAT3. Nevertheless, Res -NP inhibited CSCs proliferation and reduced the expression of metastatic and angiogenic markers, in ovo blood vascularization, NO production and MMPs expression. Res -NP delinked the association between AM -M1 and CAFs by blocking IL -6 production and also disrupted the potential connection between IL -6 and PD -L1 with considerable decrease in p-JAK2 and p-STAT3 expressions. IL -6 depletion inhibited stemness and angiogenesis in oral CSCs by downregulating PD -L1 via JAK2/STAT3 cascade. Similar observations were also observed in Res -NP treated xenograft mice. Thus, data demonstrate that CSCs growth is dependent on IL-6/PD-L1 axis. Res -NP deregulates the association between AM -M1 and CAFs along -with attenuates carcinogenesis in in vitro, in ovo, ex vivo and in vivo model systems by inhibiting PD -L1 via IL-6/JAK2/STAT3 axis. (c) 2024 Elsevier Inc. All rights reserved.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] α-Hederin inhibits interleukin 6-induced epithelial-to-mesenchymal transition associated with disruption of JAK2/STAT3 signaling in colon cancer cells
    Sun, Dongdong
    Shen, Weixing
    Zhang, Feng
    Fan, Huisen
    Xu, Changliang
    Li, Liu
    Tan, Jiani
    Miao, Yunjie
    Zhang, Haibin
    Yang, Ye
    Cheng, Haibo
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 101 : 107 - 114
  • [22] The Inflammatory Bowel Disease JAK2 and STAT3 Risk Alleles are Associated With Divergent Effects Upon IL-6 Signaling in Lymphocytes
    Jurickova, Ingrid
    Willson, Tara
    Gerad, Shaina
    Denson, Lee
    GASTROENTEROLOGY, 2010, 138 (05) : S420 - S420
  • [23] Cancer-associated fibroblasts promote stem cell-like properties of hepatocellular carcinoma cells through IL-6/STAT3/Notch signaling
    Xiong, Si
    Wang, Ronghua
    Chen, Qian
    Luo, Jing
    Wang, Jinlin
    Zhao, Zhenxiong
    Li, Yawen
    Wang, Yun
    Wang, Xiju
    Cheng, Bin
    AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (02): : 302 - +
  • [24] The IL-6/STAT3 signaling pathway mediated by radiotherapy regulates the expression of PD-L1 and affects the biological functions of esophageal cancer cells.
    Zhou, Yichen
    Zhu, Honglei
    Pang, Xuezhou
    Shen, Yang
    He, Yu
    Ma, Daiyuan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [25] Colorectal cancer-associated fibroblasts promote metastasis by up-regulating LRG1 through stromal IL-6/STAT3 signaling
    Beiping Zhong
    Bing Cheng
    Xiaoming Huang
    Qian Xiao
    Zhitong Niu
    Yu-feng Chen
    Qiang Yu
    Wenyu Wang
    Xiao-Jian Wu
    Cell Death & Disease, 13
  • [26] Colorectal cancer-associated fibroblasts promote metastasis by up-regulating LRG1 through stromal IL-6/STAT3 signaling
    Zhong, Beiping
    Cheng, Bing
    Huang, Xiaoming
    Xiao, Qian
    Niu, Zhitong
    Chen, Yu-feng
    Yu, Qiang
    Wang, Wenyu
    Wu, Xiao-Jian
    CELL DEATH & DISEASE, 2022, 13 (01)
  • [27] Tumor suppressor HIC1 is synergistically compromised by cancer-associated fibroblasts and tumor cells through the IL-6/pSTAT3 axis in breast cancer
    Sun, Xueqing
    Qu, Qing
    Lao, Yimin
    Zhang, Mi
    Yin, Xiaoling
    Zhu, Huiqin
    Wang, Ying
    Yang, Jie
    Yi, Jing
    Hao, Mingang
    BMC CANCER, 2019, 19 (01)
  • [28] Tumor suppressor HIC1 is synergistically compromised by cancer-associated fibroblasts and tumor cells through the IL-6/pSTAT3 axis in breast cancer
    Xueqing Sun
    Qing Qu
    Yimin Lao
    Mi Zhang
    Xiaoling Yin
    Huiqin Zhu
    Ying Wang
    Jie Yang
    Jing Yi
    Mingang Hao
    BMC Cancer, 19
  • [29] PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer
    Xiaohui Zhang
    Yuanyuan Zeng
    Qiuxia Qu
    Jianjie Zhu
    Zeyi Liu
    Weiwei Ning
    Hui Zeng
    Nan Zhang
    Wenwen Du
    Cheng Chen
    Jian-an Huang
    International Journal of Clinical Oncology, 2017, 22 : 1026 - 1033
  • [30] PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer
    Zhang, Xiaohui
    Zeng, Yuanyuan
    Qu, Qiuxia
    Zhu, Jianjie
    Liu, Zeyi
    Ning, Weiwei
    Zeng, Hui
    Zhang, Nan
    Du, Wenwen
    Chen, Cheng
    Huang, Jian-an
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (06) : 1026 - 1033